SV2009003368A - Macrolidos - Google Patents

Macrolidos

Info

Publication number
SV2009003368A
SV2009003368A SV2009003368A SV2009003368A SV2009003368A SV 2009003368 A SV2009003368 A SV 2009003368A SV 2009003368 A SV2009003368 A SV 2009003368A SV 2009003368 A SV2009003368 A SV 2009003368A SV 2009003368 A SV2009003368 A SV 2009003368A
Authority
SV
El Salvador
Prior art keywords
macrolidos
formula
refers
formula compounds
compounds
Prior art date
Application number
SV2009003368A
Other languages
English (en)
Inventor
Richard Allen Buzon
Mark Edward Flanagan
Zhengong Bryan Li
Thomas Victor Magee
Daniel William Widlicka
Mark Carl Noe
Reilly Usa Datta
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2009003368A publication Critical patent/SV2009003368A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

LA INVENCIÓN SE REFIERE A COMPUESTOS DE FÓRMULA (I): (VER FORMULA); EN LA QUE R1, R2, Y X SON COMO SE DEFINEN EN EL PRESENTE DOCUMENTO. LA INVENCIÓN TAMBIÉN SE REFIERE A COMPOSICIONES FARMACÉUTICAS Y PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS USANDO LOS COMPUESTOS DE FÓRMULA (I)
SV2009003368A 2007-03-13 2009-09-11 Macrolidos SV2009003368A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89447507P 2007-03-13 2007-03-13
US2337008P 2008-01-24 2008-01-24

Publications (1)

Publication Number Publication Date
SV2009003368A true SV2009003368A (es) 2009-11-09

Family

ID=39760163

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2009003368A SV2009003368A (es) 2007-03-13 2009-09-11 Macrolidos

Country Status (28)

Country Link
US (1) US20080293646A1 (es)
EP (1) EP2125851B1 (es)
JP (1) JP4468487B1 (es)
KR (1) KR20090110381A (es)
CN (1) CN101631795A (es)
AP (1) AP2009004985A0 (es)
AR (1) AR065724A1 (es)
AT (1) ATE471943T1 (es)
AU (1) AU2008224633A1 (es)
BR (1) BRPI0809002A2 (es)
CA (1) CA2680527A1 (es)
CL (1) CL2008000695A1 (es)
CR (1) CR10998A (es)
CU (1) CU20090155A7 (es)
DE (1) DE602008001611D1 (es)
DO (1) DOP2009000214A (es)
EA (1) EA200901059A1 (es)
EC (1) ECSP099627A (es)
IL (1) IL200613A0 (es)
MA (1) MA31252B1 (es)
MX (1) MX2009009074A (es)
PA (1) PA8772401A1 (es)
PE (1) PE20090106A1 (es)
SV (1) SV2009003368A (es)
TN (1) TN2009000374A1 (es)
TW (1) TW200848061A (es)
UY (1) UY30957A1 (es)
WO (1) WO2008110918A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4590C1 (ro) * 2012-03-06 2019-03-31 Pfizer Inc. Derivaţi macrociclici pentru tratamentul bolilor proliferative
CA2908575C (en) 2013-04-04 2021-11-16 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN106998685A (zh) * 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
CN105924451B (zh) * 2016-04-27 2017-12-15 国家海洋局第三海洋研究所 具有抗茶叶致病真菌活性的大环内酯化合物及制备与用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1836211T3 (pl) * 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy

Also Published As

Publication number Publication date
IL200613A0 (en) 2010-05-17
KR20090110381A (ko) 2009-10-21
CR10998A (es) 2009-09-11
CL2008000695A1 (es) 2008-09-22
UY30957A1 (es) 2008-10-31
BRPI0809002A2 (pt) 2014-11-11
WO2008110918A2 (en) 2008-09-18
AP2009004985A0 (en) 2009-10-31
CN101631795A (zh) 2010-01-20
ATE471943T1 (de) 2010-07-15
CA2680527A1 (en) 2008-09-18
CU20090155A7 (es) 2011-04-26
ECSP099627A (es) 2009-10-30
MX2009009074A (es) 2009-09-28
TN2009000374A1 (fr) 2010-12-31
WO2008110918A3 (en) 2009-01-29
EP2125851A2 (en) 2009-12-02
EP2125851B1 (en) 2010-06-23
JP2010521448A (ja) 2010-06-24
DE602008001611D1 (en) 2010-08-05
PE20090106A1 (es) 2009-02-08
US20080293646A1 (en) 2008-11-27
MA31252B1 (fr) 2010-03-01
DOP2009000214A (es) 2009-10-31
TW200848061A (en) 2008-12-16
AR065724A1 (es) 2009-06-24
JP4468487B1 (ja) 2010-05-26
PA8772401A1 (es) 2008-11-19
EA200901059A1 (ru) 2010-02-26
AU2008224633A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
PA8855001A1 (es) Monocarbamas
ECSP11010804A (es) Compuestos orgánicos
ECSP10010722A (es) Compuestos orgánicos
EA201170772A1 (ru) Органические соединения
UY32543A (es) Análogos de isoxazol-3(2h)-ona como agentes terapéuticos
UY30789A1 (es) Derivados de adenina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
UY32730A (es) Inhibidores de cyp17
GT200800170A (es) Compuestos de n-formil-hidroxilamina
NI201000164A (es) Hidroximetil pirrolidinas como agonistas del receptor adrenérgico beta 3.
ECSP11010880A (es) Compuestos orgánicos
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
CR20120264A (es) Compuestos
CR20110046A (es) Amidofenoxiindazoles utiles como inhibidores de c-met
ECSP11010760A (es) Derivados de quinoxalindiona
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
PA8792401A1 (es) Fenilendiaminas
CO6341625A2 (es) Derivados de indol como agentes anticáncer
SV2009003368A (es) Macrolidos
CL2011003123A1 (es) Compuestos derivados de ciclopentanamida sustituidos; composicion farmaceutica; proceso de obtencion; y uso en el tratamiento o la profilaxis de la diabetes, aterosclerosis, entre otras.
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
UY32447A (es) Derivados de 3-benzofuranilindol-2-ona sustituidos en 3, su preparacion y su aplicacion en terapia
BR112012012905A2 (pt) derivados de difenil azepina como inibidores da reabsorção de monoamina

Legal Events

Date Code Title Description
FD Lapse